New Science Ventures
North America, Connecticut, United States, Greenwich
Description
New Science Ventures is a venture capital firm focused on investments in life sciences and information technology companies.
Investor Profile
New Science Ventures has made 82 investments, with 2 in the past 12 months and 37% as lead.
Stage Focus
- Series B (33%)
- Series A (22%)
- Series Unknown (13%)
- Series D (12%)
- Series C (9%)
- Series E (5%)
- Seed (2%)
- Private Equity (1%)
- Angel (1%)
- Convertible Note (1%)
Country Focus
- United States (72%)
- United Kingdom (11%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Belgium (9%)
- The Netherlands (5%)
- Germany (2%)
- France (1%)
Industry Focus
- Health Care
- Biotechnology
- Medical
- Therapeutics
- Manufacturing
- Software
- Medical Device
- Electronics
- Information Technology
- Pharmaceutical
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
